Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cis-3-Hexenol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | RXRA | P19793 | 2/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.47 |
| ▸ | F7 | P08709 | 3/20 | 0.47 |
| ▸ | F3 | P13726 | 3/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | PPARD | Q03181 | 2/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cis-3-Hexenol SCHEMBL28740459 | 1.00 | ALDH1A1 (0.50) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| Cis-3-Hexenol SCHEMBL28042280 | 1.00 | ALDH1A1 (0.50) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| Acetic Acid SCHEMBL18339443 | 0.93 | ALDH1A1 (0.61) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| Acetic Acid SCHEMBL20721902 | 0.93 | ALDH1A1 (0.61) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| Cis-3-Hexenol SCHEMBL7952091 | 0.88 | ALDH1A1 (0.48) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| Cis-3-Hexenol SCHEMBL28510274 | 0.88 | ALDH1A1 (0.54) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| Cis-3-Hexenol SCHEMBL309687 | 0.87 | — | — | |
| Cis-3-Hexenol SCHEMBL112920 | 0.87 | — | — | |
| Cis-3-Hexenol SCHEMBL1448560 | 0.87 | ALDH1A1 (0.42) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| Cis-3-Hexenol SCHEMBL96295 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024175295-A1 | DETERGENTS AND CLEANING AGENTS COMPRISING DISPERSIN AND FRAGRANCE | HENKEL AG & CO. KGAA (DE) | 2024-08-29 | — | — | WO | claimed |
| CN-115769818-B | Application of (cis) -3-hexenol acetate in inducing spodoptera frugiperda to spawn and serve as spodoptera frugiperda attractant | 华南农业大学 | 2023-05-12 | — | — | CN | claimed |
| CN-115769818-A | Application of (cis) -3-hexenol acetate in inducing spodoptera frugiperda to lay eggs and serving as spodoptera frugiperda attractant | 华南农业大学 | 2023-03-10 | — | — | CN | claimed |
| CN-102511493-B | Liriomyza sativae attractant | HANGZHOU ZHIBAO CLAY FERTILIZER STATION | 2014-06-18 | — | — | CN | claimed |
| CN-106459939-B | Lipase variants and polynucleotides encoding same | 诺维信公司 | 2026-05-22 | — | — | CN | disclosed |
| US-20260132388-A1 | LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS | NOVOZYMES A/S (DK) | 2026-05-14 | — | — | US | disclosed |
| EP-4717756-A2 | LIPASE VARIANTS AND DETERGENT COMPOSITIONS | Novozymes A/S (DK) | 2026-04-01 | — | — | EP | disclosed |
| US-12559736-B2 | Lipase variants and polynucleotides encoding same | NOVOZYMES A/S (DK) | 2026-02-24 | — | — | US | disclosed |
| US-12529017-B2 | Detergent composition comprising a lipase | NOVOZYMES A/S (DK) | 2026-01-20 | — | — | US | disclosed |
| US-20250382594-A1 | METHODS OF REDUCING ODOR | NOVOZYMES A/S (DK) | 2025-12-18 | — | — | US | disclosed |
| US-12492387-B2 | Lipase variants and microcapsule compositions comprising such lipase variants | NOVOZYMES A/S (DK) | 2025-12-09 | — | — | US | disclosed |
| US-20250368924-A1 | LIPASE VARIANTS AND COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS | NOVOZYMES A/S (DK) | 2025-12-04 | — | — | US | disclosed |
| EP-1342775-B1 | Hetero spiro compound as perfuming and flavoring ingredient | FIRMENICH & CIE (CH) | 2005-08-24 | — | — | EP | disclosed |
| US-20050140032-A1 | Device for dispensing active volatile liquid | FIRMENICH SA (CH) | 2005-06-30 | — | — | US | disclosed |
| EP-1467959-A1 | ACETALS OF 2,4,7-DECATRIENAL AS PERFUMING OR FLAVORING INGREDIENTS | FIRMENICH SA (CH) | 2004-10-20 | — | — | EP | disclosed |
| EP-1342775-A1 | Hetero spiro compound as perfuming and flavoring ingredient | FIRMENICH SA (CH) | 2003-09-10 | — | — | EP | disclosed |
| WO-2003062183-A1 | ACETALS OF 2,4,7-DECATRIENAL AS PERFUMING OR FLAVORING INGREDIENTS | FIRMENICH SA (CH) | 2003-07-31 | — | — | WO | disclosed |
| EP-1329497-A2 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2003-07-23 | — | — | EP | disclosed |
| EP-0955290-B1 | Unsaturated ketones and their use in perfumery | FIRMENICH & CIE (CH) | 2003-03-19 | — | — | EP | disclosed |
| US-6177400-B1 | IMPROVING OR MODIFYING THE ODOR OF A PERFUME BY ADDING 4,6,6-TRIMETHYL-1,(3)-CYCLOHEX(ADI)ENE 1-SUBSTITUTED WITH ESTERS, ETHERS OR KETONES, SUCH AS (E)-1-(4,6,6-TRIMETHYL-1,3-CYCLOHEXADIEN-1-YL)-2-BUTEN-1-ONE | FIRMENICH SA (CH) | 2001-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559736-B2 | Lipase variants and polynucleotides encoding same | LPL, PNLIP, LIPG | ALDH1A1 3681/4885CYP19A1 3000/4885PPARG 3690/4885 |
| US-20260132388-A1 | LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS | LIPE, LPL, PNLIP | ALDH1A1 3173/4885CYP19A1 1002/4885PPARG 2458/4885 |
| US-12529017-B2 | Detergent composition comprising a lipase | MGLL, LPL, LIPC | ALDH1A1 2525/4885CYP19A1 1483/4885PPARG 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.